-
401
MPTP Neurotoxicity and Testosterone Induce Dendritic Remodeling of Striatal Medium Spiny Neurons in the C57Bl/6 Mouse
Published 2011-01-01“…Parkinson's Disease…”
Get full text
Article -
402
Cognitive Training in Parkinson’s Disease: A Review of Studies from 2000 to 2014
Published 2016-01-01“…Parkinson's Disease…”
Get full text
Article -
403
Risk of Dementia in Patients with Depression or Parkinson’s Disease: A Retrospective Cohort Study
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
404
Sleep Quality and Levodopa Intestinal Gel Infusion in Parkinson’s Disease: A Pilot Study
Published 2018-01-01“…Parkinson's Disease…”
Get full text
Article -
405
Invalid Self-Assessment of Olfactory Functioning in Parkinson’s Disease Patients May Mislead the Neurologist
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
406
Prevalence and Factors Associated with Drooling in Parkinson’s Disease: Results from a Longitudinal Prospective Cohort and Comparison with a Control Group
Published 2023-01-01“…Parkinson's Disease…”
Get full text
Article -
407
Are Verbal Fluency and Nonliteral Language Comprehension Deficits Related to Depressive Symptoms in Parkinson’s Disease?
Published 2012-01-01“…Parkinson's Disease…”
Get full text
Article -
408
Elevated Serum Ceruloplasmin Levels Are Associated with Higher Impulsivity in People with Parkinson’s Disease
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
409
Nomogram for Prediction of Postoperative Delirium after Deep Brain Stimulation of Subthalamic Nucleus in Parkinson’s Disease under General Anesthesia
Published 2022-01-01“…Parkinson's Disease…”
Get full text
Article -
410
Balance and Gait Improvements of Postoperative Rehabilitation in Patients with Parkinson’s Disease Treated with Subthalamic Nucleus Deep Brain Stimulation (STN-DBS)
Published 2019-01-01“…Parkinson's Disease…”
Get full text
Article -
411
17α-Ethynyl-androst-5-ene-3β,7β,17β-triol (HE3286) Is Neuroprotective and Reduces Motor Impairment and Neuroinflammation in a Murine MPTP Model of Parkinson’s Disease
Published 2012-01-01“…Parkinson's Disease…”
Get full text
Article -
412
Trends in Antiparkinsonian Medication Use in New Zealand: 1995–2011
Published 2014-01-01“…Parkinson's Disease…”
Get full text
Article -
413
Potential Neuroprotective Effect of the Endocannabinoid System on Parkinson’s Disease
Published 2024-01-01“…Parkinson's Disease…”
Get full text
Article -
414
Polymorphisms of ACMSD-TMEM163, MCCC1, and BCKDK-STX1B Are Not Associated with Parkinson’s Disease in Taiwan
Published 2019-01-01“…Parkinson's Disease…”
Get full text
Article -
415
The Possible Clinical Predictors of Fatigue in Parkinson’s Disease: A Study of 135 Patients as Part of International Nonmotor Scale Validation Project
Published 2011-01-01“…Parkinson's Disease…”
Get full text
Article -
416
Lower Urinary Tract and Gastrointestinal Dysfunction Are Common in Early Parkinson’s Disease
Published 2020-01-01“…Parkinson's Disease…”
Get full text
Article -
417
Behavioral and Emotional Dysfunction in Parkinson’s Disease
Published 2019-01-01“…Parkinson's Disease…”
Get full text
Article -
418
Depression in Parkinson’s Disease: The Contribution from Animal Studies
Published 2017-01-01“…Parkinson's Disease…”
Get full text
Article -
419
Enhanced Neuroprotective Effects of Coadministration of Tetrandrine with Glutathione in Preclinical Model of Parkinson’s Disease
Published 2015-01-01“…Parkinson's Disease…”
Get full text
Article -
420
Accuracy of Markerless 3D Motion Capture Evaluation to Differentiate between On/Off Status in Parkinson’s Disease after Deep Brain Stimulation
Published 2018-01-01“…Parkinson's Disease…”
Get full text
Article